Zydus Lifesciences has informed that it enclosed a copy of press release dated April 24, 2023 titled ‘Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules, 0.5 g and 1 g’.
The above information is a part of company’s filings submitted to BSE.